Telehealth & Digital Health

With 12% weight loss in a pivotal trial, Vincentage Pharma's VCT220 pill is set to challenge injectables and reshape China's obesity drug market.

Age-tech leader SafelyYou hires strategy veteran Joelle Poe, signaling a major push to redefine senior living with advanced AI and person-centered care.

Beyond fat removal, a new wave of cosmetic surgery in Dubai uses advanced tech to craft athletic, natural bodies, making the city a global beauty hub.

A new partnership between Hong Kong's PAIR and the UK's Cambridge NeuroWorks aims to accelerate brain health innovations through a global seminar series.

Hong Kong's PolyU is leading a global charge, uniting scientists and masters to prove the medical power of Tai Chi and Qigong.

Glucotrack seeks FDA trial approval for its revolutionary 3-year implantable glucose monitor, racing against financial clocks to change diabetes care.

The biotech firm is set to launch its first commercial products, using an innovative strategy to tackle long-neglected markets in women's healthcare.

A local partnership's stunning success in reducing infant mortality is gaining national attention, offering a blueprint for how to save mothers and babies.

As misinformation clouds the perimenopause conversation, Flo Health is launching new, doctor-backed tools to bring data-driven clarity to millions of women.

With a major new financing round, BlueWind Medical is set to expand access to its innovative Revi® System for urgency urinary incontinence.

The biopharma posts record Q1 revenue and profit, driven by its flagship DefenCath and a key acquisition, while a promising pipeline signals future growth.

Dr. Amie Hornaman's bestseller, The Thyroid Fix, confronts medical gaslighting, empowering women to look beyond 'normal' lab results for answers.

On May 18, competitors like Ulta and CVS join forces for National Sun Responsibly Day, an urgent call to make daily sun protection a life-saving habit.

A new partnership aims to solve the massive underdiagnosis of a severe genetic disorder by offering free testing, a move with deep strategic implications.

As data breach costs soar, a new service embeds HIPAA compliance from day one, aiming to save digital health startups from costly, delayed launches.

A $25M payment from partner Chiesi catapults Protalix to a profitable quarter, funding a promising new gout therapy and a broader rare disease strategy.

Intense competition and NHS staff shortages are pushing thousands of qualified British students to pursue medical degrees at international universities.

With a new CEO, a half-billion-dollar war chest, and a novel drug pipeline, Damora Therapeutics is making an aggressive play to redefine blood cancer treatment.

A Belgian firm's new biologic gel for diabetic foot ulcers gets a key FDA green light, offering hope against a leading cause of amputations.

With demand for blood and plasma soaring, Canadian Blood Services is betting on national pride to solve a critical shortage. But can a new campaign work?